{
  "docId": "019de070-701b-7388-a208-3e38cd293d9a",
  "docSlug": "f771dd63c4f3642a1d968d8585ded9c7",
  "documentTitle": "Evotec | Investor Day Presentation Deck | 103 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 103,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "before_after",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a split-panel layout to contrast pre-clinical results with clinical trial parameters.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-701b-7388-a208-3e38cd293d9a/30",
  "deckHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a",
  "deckJsonHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a.json",
  "deckAnchorHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.51,
        "y": 0.55
      },
      "kind": "callout",
      "text": "Very good synergy with Just – Evotec Biologics\nReference case for “Pandemic preparedness”",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67e063c6-ca61-4e1f-8f18-269549b1dd75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.38,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "chart",
      "text": "CHIKV Genomes/ml of Plasma vs Days Post Infection",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e6c672c-6891-4b55-83d6-df4c3d195a3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.04,
        "y": 0.35
      },
      "kind": "list",
      "text": "Strong neutralising activity in mice and non human primates\nData suggest long half-life",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f1e1305-8a94-4d37-a674-272dca577328",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.51,
        "y": 0.35
      },
      "kind": "list",
      "text": "Single ascending IV doses of EVT894 (0.3, 1, 3, 10, 20 mg/kg)\n8 subjects (6 active, 2 placebo) per cohort\nProjected duration 14 months, started Nov 2020",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c135a1e3-1584-43c0-9d40-2d226f652a4a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.04,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Pre-clinical development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17518004-6826-4f94-a8bc-cc445c65f5a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.51,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Phase I FIH study",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f0854e8-8635-42bf-8a56-7f008de4768e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.25,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1) www.clinicaltrials.gov: NCT04441905; Sponsor: NIH Site: Duke Clinical Research Center",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "895555c2-d49b-4be9-b02f-30978ff0d6bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.25,
        "y": 0.18
      },
      "kind": "title",
      "text": "EVT894: FIH study at Duke University initiated November 2020",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bbc96b36-7a89-47a0-afb1-435f0e970505",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.25,
        "y": 0.1
      },
      "kind": "title",
      "text": "Strong data in various in vivo models lead to Phase I",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7db70547-079d-41ec-bf07-e592176eede6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "327c08ba-18a0-40ec-9b81-2420c9ce7d30",
      "evidence": "The slide presents pre-clinical data and Phase I results, showing a clear progression from 'before' to 'after'.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "c2792ce0-288d-4bc7-9078-c85a1a5b3392",
      "evidence": "Split layout contrasting pre-clinical data with clinical trial design",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 15,
      "beatId": "bff745b7-4060-47df-8173-1e462b2c6fda",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides evidence of Evotec's strategy delivering growth and value potential.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}